Akers Bio logo
Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens
08 avr. 2020 09h25 HE | Akers Biosciences Inc.
Thorofare, New Jersey, April 08, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that its...
RejuvenateMuscle.com
Support Immune Function and Muscle Health With Rejuvenate During Prolonged Inactivity
07 avr. 2020 12h05 HE | Element Nutrition, Inc.: Rejuvenate
BURLINGTON, Ontario, April 07, 2020 (GLOBE NEWSWIRE) -- While people are stockpiling common immune-strengthening supplements like vitamins C, D and zinc, one group of overlooked nutrients that are...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Inc. Reports Revenues Up 850% for Q2
29 août 2019 13h53 HE | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - Therapeutics Solutions International Inc. (OTC: TSOI) today reports that its second-quarter 2019 revenues increased 850%, as...
Therapeutics Solutions International, Inc LOGO.png
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
26 août 2019 09h00 HE | Therapeutic Solutions International, Inc.
OCEANSIDE, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today positive results from a pilot clinical trial...
GreyWolf-final.jpg
Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility
11 févr. 2019 01h00 HE | Grey Wolf Therapeutics
Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility Grey Wolf...
Trivedi Global, Inc. and Jagdish Singh Announce Research Results of Biofield Energy Treated Nutraceutical Formulated to Enhance Immunity and Combat Inflammatory and Autoimmune Disorders
30 mai 2018 13h30 HE | Trivedi Global, Inc.
Cleveland, Ohio, May 30, 2018 (GLOBE NEWSWIRE) -- Jagdish Singh, an energy healer with scientific validation, today announces the impact of a biofield energy treated proprietary supplement to...
Immudyne Announces Launch of INR Wellness Immune Support Product Line
19 mars 2018 09h01 HE | ImmuDyne, Inc.
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC healthcare products, is pleased to announce...
PreveCeutical™ Medic
PreveCeutical™ Medical Inc. Begins Trading on the Frankfurt Stock Exchange
01 août 2017 08h30 HE | PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the listing of its common shares for trading on the...
Commence Bio to Present at 2016 Cell & Gene Meeting on the Mesa
28 sept. 2016 12h37 HE | Commence Bio
SPARKS, MD--(Marketwired - September 28, 2016) - Commence Bio, Inc., a biotechnology company focused on developing breakthrough immunotherapies using its proprietary STaRT™ platform, announced today...
Stellar Biotechnologies Awarded $498,560 Phase IIB National Science Foundation (NSF) Grant
29 août 2011 16h05 HE | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Aug 29, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce that the National Science Foundation (NSF) has...